SKI Market

A+| A| A-|

Indian Indices

Sensex

77,550.25 918.60
( 1.20%)

Global Indices

Nasdaq

47,930.49 -276.32
(-0.57%)

Dow Jones

6,837.38 -8.28
(-0.12%)

Hang Seng

56,916.27 1,020.95
(1.83%)

Nikkei 225

10,596.33 -7.15
(-0.07%)

Forex

USD-INR

92.50 0.06
(0.07%)

EUR-INR

108.05 0.09
(0.08%)

GBP-INR

124.08 0.03
(0.03%)

JPY-INR

0.58 0.00
(-0.25%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.5510998

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

22.16

102829.74

EPS(TTM)

Face Value()

Div & Yield %

55.59

0.65

Back

CSL Finance standalone net profit rises 37.03% in the September 2025 quarter

Nov 14,2025

Net profit of CSL Finance rose 37.03% to Rs 24.46 crore in the quarter ended September 2025 as against Rs 17.85 crore during the previous quarter ended September 2024. Sales rose 17.78% to Rs 63.67 crore in the quarter ended September 2025 as against Rs 54.06 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	63.67	54.06	18
OPM %	78.59	74.82	-
PBDT	29.40	25.16	17
PBT	28.86	24.71	17
NP	24.46	17.85	37

77,550.25 918.60 ( 1.20%)

47,930.49 -276.32 (-0.57%)

6,837.38 -8.28 (-0.12%)

56,916.27 1,020.95 (1.83%)

10,596.33 -7.15 (-0.07%)

92.50 0.06 (0.07%)

108.05 0.09 (0.08%)

124.08 0.03 (0.03%)

0.58 0.00 (-0.25%)